Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 6:42 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1993–2016 of 21,040 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: ONE Clear all

Conditions: Anxiety, Anxiety Disorders
Interventions: Behavioral Tasks with imaging; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 22 Years to 55 Years
Enrollment: 163 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2030
U.S. locations: 2
States / cities: Atlanta, Georgia

Conditions: Cervical Cancer, Behavior
Interventions: Care Group Cervical Cancer Screening Education Curriculum; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 30 Years to 59 Years
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Ewing's Family Tumors, Renal Tumors, Hepatoblastoma, Rhabdomyosarcoma, Soft Tissue Sarcoma, Primary Malignant Brain Neoplasms, Retinoblastoma, Medulloblastoma, Supra-tentorial Primative Neuro-Ectodermal Tumor (PNET), Atypical Teratoid/Rhabdoid Tumor (AT/RT), CNS Tumors, Germ Cell Tumors
Interventions: Ifosfamide, Etoposide, Mesna, G-CSF, Busulfan, Melphalan, Thiotepa, Autologous stem cell infusion, Radiation, Carboplatin, Paclitaxel, Leukapheresis, Anti-seizure prophylaxis, Ursodiol; Drug · Biological · Radiation + 1 more
Lead sponsor: Masonic Cancer Center, University of Minnesota; Other
Eligibility: Up to 70 Years
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2024
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Healthy Volunteers
Interventions: OLT1177 Gel, Placebo gel; Drug
Lead sponsor: Olatec Therapeutics, Inc.; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 1
States / cities: College Station, Texas

Conditions: Lung Cancer
Interventions: AmDTx-PCSP, AmDTx-2048, Questionnaires; Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 7
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more

Conditions: Alcohol Drinking, Suicide, Attempted, Adolescent Behavior
Interventions: iASIST; Behavioral
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 13 Years to 17 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Crohn's Disease
Interventions: Nitazoxanide, Placebo; Drug · Other
Lead sponsor: Romark Laboratories L.C.; Industry
Eligibility: 18 Years and older
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 13
States / cities: Tampa, Florida • Zephyrhills, Florida • Marietta, Georgia + 10 more

Conditions: Meningococcal Meningitis
Interventions: MenACWY-CRM conjugate vaccine, Licensed comparator; Biological
Lead sponsor: Novartis Vaccines; Industry
Eligibility: 11 Years to 18 Years
Enrollment: 389 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2012
U.S. locations: 32
States / cities: Birmingham, Alabama • Fremont, California • Fresno, California + 21 more

Conditions: Pre-Frail Older Adults
Interventions: Pharyngeal Swallowing Exercises, Protein Supplementation, MRI; Behavioral · Dietary Supplement · Device
Lead sponsor: NYU Langone Health; Other
Eligibility: 65 Years and older
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 2
States / cities: New York, New York

Conditions: Antimicrobial Prophylaxis
Interventions: daptomycin 6 mg/kg IV; Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Tumors
Interventions: S-1, FT; Drug
Lead sponsor: Taiho Oncology, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 3
States / cities: Scottsdale, Arizona • Santa Monica, California • New Haven, Connecticut

Conditions: Chronic Pain, Widespread
Interventions: Near Non-Social, Near Social, Far Non-Social, Far Social; Other
Lead sponsor: Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 105 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Ithaca, New York

Conditions: Lymphoma, B-Cell
Interventions: Roflumilast; Drug
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Scar
Interventions: Topical Tocotrienol (TCT), Oral Tocotrienol Capsules (TCT), Tamoxifen Cream, Placebo cream, placebo capsule; Device · Dietary Supplement
Lead sponsor: Chandan K Sen; Other
Eligibility: 18 Years to 50 Years
Enrollment: 101 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2018
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Healthy
Interventions: PF-04447943, Placebo; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 1
States / cities: Glendale, California

Conditions: Prosthetic Joint Infection of Knee
Interventions: Intervention 1: Alternating Magnetic Field Treatment, Intervention 2 - Sham Treatment, Debridement, Antibiotics, Implant Retention; Device · Procedure
Lead sponsor: Solenic Medical, Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 165 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 2
States / cities: New Albany, Ohio • Tulsa, Oklahoma

Conditions: Parkinson Disease, Ketosis
Interventions: Ketone Ester Elite endurance Nutrition Drink, Stool Sample; Dietary Supplement · Other
Lead sponsor: University of Florida; Other
Eligibility: 40 Years to 75 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Sepsis
Interventions: Ketamine, Normal Saline placebo; Drug
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 21 Years to 100 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Healthy
Interventions: Oral Psilocybin, IV Psilocybin; Drug
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 25 Years to 65 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Myopia
Interventions: Bausch & Lomb Test lens, Ciba Vision soft contact lens; Device
Lead sponsor: Bausch & Lomb Incorporated; Industry
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Cocaine Use Disorder, Cocaine Dependence
Interventions: Soterix Medical mini-CT tDCS stimulator; Device
Lead sponsor: Soterix Medical; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Solid Tumors, Lymphoma
Interventions: PU-H71; Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years to 120 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Mantle Cell Lymphoma
Interventions: Acalabrutinib, Ublituximab, Umbralisib; Drug · Biological
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Duarte, California

Conditions: Cervical Disc Disease, Degenerative Disc Disease
Interventions: NuVasive Simplify Cervical Artificial Disc; Device
Lead sponsor: NuVasive; Industry
Eligibility: Not listed
Enrollment: 131 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 10
States / cities: Orange, California • Santa Monica, California • Thornton, Colorado + 7 more

Search by objective public record fields.

Quantifying Multi-step Avoidance in Anxiety

Reducing Barriers and Sustaining Utilization of a Cervical Cancer Screening Program in Rural Senegal

Auto Transplant for High Risk or Relapsed Solid or CNS Tumors

Phase 1 Safety Study of Single and Multi-Dose Topically Applied OLT1177 Gel in Healthy Subjects

A Study Comparing Mindfulness Apps to Decrease Anxiety in People With Lung Cancer

Brief Alcohol Intervention and mHealth Booster for Suicidal Adolescents

Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's Disease

Evaluation of Persistence of Anti-meningococcal Bactericidal Antibodies Among Adolescents Who Previously Received MenACWY Conjugate Vaccine

Pharyngeal Exercise (Plus Protein)

A Pilot Study of Daptomycin for Antimicrobial Prophylaxis

A Phase 1, Open-Label, Randomized, Cross-Over, Pharmacokinetic Study Evaluating the Effect of S-1 on Advanced Solid Tumors

Effects of Social Presence and Perception in Virtual Reality on Pain

Study of Roflumilast in Combination With Standard Chemotherapy for High-risk Diffuse Large B-cell Lymphoma

Efficacy Of Tocotrienol a Natural Vitamin E In Biopsy Wound

Study Of Single Ascending And Multiple Doses Of PF-04447943 In Japanese Subjects.

Sola2 AMF Knee System Added to Surgery and Antibiotics in Adults With Knee Implant Infection

Effect of Ketone Esters in Parkinson's Disease

Immunomodulatory Properties of Ketamine in Sepsis

Bioavailability Study of Psilocybin in Normal Adults

A Study to Evaluate the Product Feasibility of a New Silicone Hydrogel Contact Lens

TDCS for Cocaine Addiction Craving

PU-H71 in Patients With Solid Tumors and Low-Grade Non-Hodgkin's Lymphoma That Have Not Responded to Standard Treatment

Acalabrutinib, Umbralisib, and Ublituximab for the Treatment of Previously Untreated Mantle Cell Lymphoma

Long-term Assessment of the Safety and Performance of the NuVasive Simplify Disc